Dr. Matheen Khuddus, M.D.
What this data tells you about Dr. Khuddus
Dr. Matheen Khuddus is a cardiovascular disease in Gainesville, FL, with 19 years in practice. Based on federal Medicare data, Dr. Khuddus performed 6,266 Medicare services across 4,310 unique beneficiaries.
Between the years covered by Open Payments, Dr. Khuddus received a total of $158,610 from 63 pharmaceutical and/or device companies across 587 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Khuddus is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Electrocardiogram (EKG), 12-lead | 1,136 | $10 | $34 |
| Office visit, established patient (30-39 min) | 899 | $88 | $216 |
| Regadenoson injection (Lexiscan) for heart stress test | 453 | $45 | $113 |
| Echocardiogram, transthoracic | 329 | $131 | $414 |
| Remote patient monitoring device, 30 days | 285 | $36 | $106 |
| Remote patient monitoring management, 20 min/month | 193 | $36 | $100 |
| Office visit, established patient, complex (40-54 min) | 185 | $131 | $293 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 164 | $86 | $236 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 152 | $50 | $142 |
| Remote pacemaker monitoring, 90 days | 140 | $21 | $63 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 132 | $309 | $798 |
| Hospital follow-up visit, moderate complexity | 123 | $62 | $149 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 122 | $16 | $54 |
| Remote pacemaker/defibrillator monitoring, 90 days | 112 | $14 | $52 |
| Initial hospital admission, high complexity | 96 | $136 | $415 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 95 | $27 | $70 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 90 | $19 | $55 |
| Heart muscle strain imaging | 88 | $26 | $80 |
| Office visit, established patient (20-29 min) | 85 | $65 | $147 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 83 | $316 | $952 |
| New patient office visit (45-59 min) | 81 | $117 | $334 |
| Programming of dual lead pacemaker system | 77 | $57 | $117 |
| Hospital follow-up visit, high complexity | 76 | $94 | $213 |
| Physician review, interpretation, and patient management of home inr testing for patient with either mechanical heart valve(s), chronic atrial fibrillation, or venous thromboembolism who meets medicare coverage criteria; testing not occurring more frequent | 74 | $6 | $18 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 68 | $23 | $111 |
| Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | 67 | $31 | $81 |
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 61 | $1,138 | $2,954 |
| Cardiac catheterization | 60 | $209 | $644 |
| Telephone medical discussion with physician, 11-20 minutes | 55 | $67 | $154 |
| Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | 54 | $14 | $40 |
| Ultrasound of heart, follow-up | 43 | $68 | $208 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 43 | $17 | $54 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 43 | $16 | $50 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 40 | $17 | $54 |
| Injection, midazolam hydrochloride, per 1 mg | 36 | $0 | $1 |
| Heart rhythm recording of continous external ekg over 8-15 days | 35 | $8 | $58 |
| Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes | 31 | $9 | $22 |
| Coronary stent placement | 29 | $438 | $1,290 |
| Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | 27 | $8 | $58 |
| Injection, fentanyl citrate, 0.1 mg | 27 | $1 | $1 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 26 | $76 | $206 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 26 | $17 | $54 |
| Insertion of tube in left lower heart chamber, coronary artery and bypass graft for diagnosis with review by radiologist | 24 | $268 | $731 |
| Initial hospital admission, moderate complexity | 24 | $103 | $280 |
| Blood draw (venipuncture) | 23 | $8 | $10 |
| Blood test, basic group of blood chemicals (calcium, ionized) | 23 | $13 | $23 |
| Red blood cell concentration measurement | 23 | $2 | $7 |
| Blood count, hemoglobin | 23 | $2 | $7 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 21 | $38 | $102 |
| External shock to heart to regulate heart beat | 15 | $85 | $322 |
| Telephone medical discussion with physician, 5-10 minutes | 14 | $37 | $100 |
| Review by radiologist of both arms or legs arteries image | 12 | $126 | $392 |
| Telephone medical discussion with physician, 21-30 minutes | 12 | $99 | $224 |
| Electrocardiogram (ecg) 2-day continuous | 11 | $13 | $52 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
The majority of payments (68%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in cardiovascular disease and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 3% for cardiovascular disease in FL.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Khuddus is a electrophysiology & remote specialist, with above-average Medicare volume (top 15% in FL), and high industry engagement (speaking/promotional, top 3%), with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Khuddus experienced with electrocardiogram (ekg), 12-lead?
Does Dr. Khuddus receive payments from pharmaceutical companies?
How do Dr. Khuddus's costs compare to other cardiovascular diseases in Gainesville?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology